Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with<i>Clostridium Difficile</i>(RAPID): a randomised placebo controlled trialGiles Major, Robert E. Spiller, Alan Montgomery et al.|Gut|2018Cited by 34
Whole genomes from bacteria collected at diagnostic units around the world 2020Sidsel Nag, Asta Dambrauskienė, Gunhild Larsen et al.|Scientific Data|2023Cited by 9
PWE-050 Follow-on rifaximin for the prevention of recurrence in clostridium difficile associated diarrhoea: a randomised controlled trialGiles Major, Lucy Bradshaw, Nafisa Boota et al.|Unknown|2017Cited by 0